Eating disorders, Manufacturing and Sleep and mental health

Search:

DAY

WEEK

MONTH

YEAR

Select your country:
Sign up | Log in

Eating disorders

Manufacturing

Sleep and mental health

NRx Pharmaceuticals Applies for FDA National Priority Voucher for Intravenous Ketamine (NRX-100)

Psychiatric Times

JUNE 23, 2025

1 The newly announced CNPV pathway was introduced by FDA Commissioner Marty Makary, MD, MPH, on June 17, 2025, and is intended to expedite reviews for medications that address US public health priorities. The CNPV program, introduced by FDA Commissioner Marty Makary, aims to reduce review times to 1-2 months for eligible applications.

Mad in America’s 10 Most Popular Articles in 2023

Mad in America

DECEMBER 30, 2023

Universal DBT in Schools Increases Anxiety, Depression, Family Conflict In October, Peter Simons wrote about research asking if dialectical behavior therapy (DBT) can actually make kids’ mental health worse. Mental Disorder Has Roots in Trauma and Inequality, Not Biology Allan M.

Dialectical Behavior Therapy

Dialectical Behavior Therapy Trauma and the brain Childhood trauma Sleep and mental health

Mental Health Clinicians

NRx Pharmaceuticals Applies for FDA National Priority Voucher for Intravenous Ketamine (NRX-100)

Mad in America’s 10 Most Popular Articles in 2023

Stay Connected